|
| Subject : | RE: RE: RE: RE: RE: | | MessageDate : | 5/22/2018 6:40:06 PM | | Posted By : | Benny | | Email : | isiah4r@lycos.com | | Message : | Other amount http://www.iris-community-management.fr/drugs-medcom-review-8680.pdf drugs-med.com fake Although highly leveraged, Rite Aid has executed a series ofrefinancings this year that have reduced its interest expense byUSD85m and pushed out its maturity ladder to 2018 - both ofwhich have put the cost of protection on the name at least onenotch higher than Rite Aid's current B3/B-/B- ratings.
***---REPLIED TO MESSAGE BELOW---***
Other amount http://www.iris-community-management.fr/drugs-medcom-review-8680.pdf drugs-med.com fake Although highly leveraged, Rite Aid has executed a series ofrefinancings this year that have reduced its interest expense byUSD85m and pushed out its maturity ladder to 2018 - both ofwhich have put the cost of protection on the name at least onenotch higher than Rite Aid's current B3/B-/B- ratings.
|
Parent Message
RE: RE: RE: RE: - Clint (89) - 5/20/2018 6:50:28 AM
Replies
No Current Replies
|
Post A Reply To This Message
|
|